Published in

Section 5: Patient Safety and Quality Assurance, 2019

DOI: 10.1136/ejhpharm-2019-eahpconf.518

Links

Tools

Export citation

Search in Google Scholar

5PSQ-085 Metabolic disorders in patients treated with second-generation antipsychotics: an opportunity for pharmaceutical intervention

This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown